Vaccines and Related Biological Products Advisory Committee Update

"U.S. Food & Drug Administration (FDA)" <fda@xxxxxxxxxxxxxxxxxxxxxxx> · Mon, 14 Nov 2011 14:50:16 -0600

Title: 
    Vaccines and Related Biological Products Advisory Committee Update

You are subscribed to Vaccines and Related Biological Products Advisory Committee for U.S. Food & Drug Administration (FDA). This information has recently been updated.
November 16, 2011: Vaccines and Related Biological Products Advisory Committee Meeting: Draft Agenda (PDF - 23KB)
Posted 11/14/2011
November 16, 2011: Vaccines and Related Biological Products Advisory Committee Meeting: Pre-Meeting Information Document (PDF - 5.4MB)
Posted: 11/14/2011
November 16, 2011: Vaccines and Related Biological Products Advisory Committee Meeting Briefing Document: Prevnar 13™ (PCV13): Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein) Applicant: Wyeth Pharmaceuticals Inc. (PDF - 1.8MB)
Posted: 11/14/2011
November 16, 2011: Vaccines and Related Biological Products Advisory Committee Meeting: Public Roster (PDF - 40KB)
Posted: 11/14/2011
November 16, 2011: Vaccines and Related Biological Products Advisory Committee Meeting: Errata – FDA Briefing Document
Posted: 11/14/2011

Subscriber Services: 
Manage Preferences  |  Unsubscribe  |  Help with this service

Stay Connected:

This email was sent to list-fda@xxxxxxxxxxx using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420